Federal regulators cleared an entirely new way to tackle opioid addiction, approving on Thursday an implant that can help treat dependence.
The Food and Drug Administration approved Probuphine, which is an implant intended to provide a low-level dose of the addiction treatment buprenorphine. The approval comes a few weeks after the House and Senate approved competing opioid bills.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.